Anura Mobile Core SDK (M1)— 510(k) K253650

Substantially Equivalent

Nuralogix Corporation

FDA 510(k) clearance K253650 for Anura Mobile Core SDK (M1), Substantially Equivalent on 2026-06-11. Applicant: Nuralogix Corporation.

Clearance details

Applicant: Nuralogix Corporation
Product code: Code QME
Advisory panel: Cardiovascular
Date received: 2025-11-20
Decision date: 2026-06-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Toronto, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.